South Korean E-cigarette Association sues government for economic damages.

Oct.17.2022
South Korean E-cigarette Association sues government for economic damages.
South Korea's electronic cigarette association has sued the government for causing economic losses to small e-cigarette businesses with incorrect information.

The Korean e-cigarette association has filed a lawsuit against the government, accusing it of causing economic losses to small business owners involved in the e-cigarette industry by providing incorrect information.


The Korea E-cigarette Association (KECA) has accused the government's health agency, the Ministry of Health and Welfare (MOHW), of damaging the reputation of small e-cigarette businesses and causing financial problems by urging the public to stop using liquid e-cigarettes in a press release dated February 23, 2019. KECA claimed that the basis for MOHW's decision was a notice from the US Food and Drug Administration (FDA) prohibiting the sale of liquid e-cigarettes due to the use of tetrahydrocannabinol, a main culprit in the US outbreak of severe lung illness associated with vaping that claimed eight lives and resulted in a ban on vaping products by the FDA in 2019. The South Korean Health Ministry, however, confirmed only one suspected case of lung injury related to e-cigarettes at the time of the press release and said that even that case was suspected to be from a smoker. According to a study published in the Journal of Korean Medical Science in December 2021, there have been no cases of severe pneumonia or lung injuries among users of liquid e-cigarettes. Despite these findings, KECA criticized the Health Ministry for not withdrawing its strong recommendation to suspend the use of liquid e-cigarettes and accused them of neglecting their duty. KECA also took issue with a press release issued by the Korean Disease Control and Prevention Agency (KDCA) on July 21, titled "Liquid E-cigarettes Disperse More and Farther Fine Dust than Cigarettes," saying that the measurements of fine dust by the KDCA were unavoidably higher in areas of higher humidity due to the method used in measuring them. KECA further argued that the comparison of liquid e-cigarettes and tobacco in the same environment is an inappropriate research method that fails to consider the unique characteristics of liquid e-cigarettes. KECA maintained that the government has already acknowledged that e-cigarettes are safer than tobacco, citing a 2017 test by the Ministry of Food and Drug Safety (MFDS) that found harmful substances in liquid e-cigarettes to be much lower than those in tobacco. KECA also pointed out that no tar or carbon monoxide was detected in liquid e-cigarettes, and the levels of formaldehyde and acetaldehyde were 1/20th and 1/500th those in cigarettes, respectively. Despite the significant differences in harmful substance contents, KECA protested that the Health Ministry's anti-smoking campaign has created a false perception that liquid e-cigarettes are as harmful as tobacco, causing great economic and psychological harm to e-cigarette business owners. KECA's Vice President Kim Du-hwan stated that KECA would do its utmost to win a legal battle against the government by preparing all scientific evidence and logical arguments to address the unfair treatment of small e-cigarette business owners who are unable to voice their concerns. A spokesperson for the Health Ministry responded to the lawsuit by stating that the relevant authorities would thoroughly examine the details of the complaint and work with other agencies such as KDCA and MFDS to address the issues.


Statement:


This article is compiled from third-party information and is intended solely for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only for industry-related communication and research purposes.


Due to limitations in our translation abilities, this article may not accurately reflect the original text. Please refer to the original version for precise information.


2FIRSTS maintains complete alignment with the Chinese government in its positions and statements regarding domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The ownership of the compiled information belongs to the original media and authors. If there are any copyright infringements, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea’s Health Ministry says amendments to the Tobacco Business Act will take effect on April 24, bringing synthetic-nicotine e-liquid vapes under the legal definition of tobacco. The shift extends cigarette-style rules to these products, including mandatory graphic warnings, sharply limited advertising channels, stricter vending-machine placement requirements, and a ban on use in smoke-free areas, with enforcement checks slated from late April.
Feb.03 by 2FIRSTS.ai
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
Spain’s PSOE files motion to curb vaping and nicotine pouches, restricting sales channels and banning online sales
Spain’s PSOE files motion to curb vaping and nicotine pouches, restricting sales channels and banning online sales
Spain’s Socialist Party (PSOE) has registered a non-legislative motion (PNL) in Congress seeking to curb the use of vapes and nicotine pouches by restricting sales to authorised channels and banning sales online and in non-specialist shops. The proposal says the current “lack of control” in commercialisation facilitates tax evasion and breaches existing health and environmental rules.
Mar.03 by 2FIRSTS.ai
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
The Tobacco and Vapes Bill has entered the report stage in the UK House of Lords, with further examination scheduled to begin on February 24, 2026. The legislation aims to create the first “smoke-free generation” by ensuring that individuals who are 15 years old or younger in 2026 can never legally be sold tobacco.
Regulations
Feb.22
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11